Plymouth Meeting, PA, United States of America

David M Burns

This inventor holds 43 USPTO granted patents and 13 published patent applications, plus 5 CIPO patents and 10 EPO patents, primarily in PI3K Inhibitors. Top assignees: Incyte Corporation, Incyte Holdings Corporation. Active years: 2009-2026.

USPTO Granted Patents = 43 (Patent Applications = 13)

% Patents Active = 97.7

CIPO Patents = 5 (Patent Applications = 10)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 5.3

ph-index = 13

Forward Citations = 498(Granted Patents)

Location History:

Lavergne, Rutherford County, TN (US) (2010)
Lavergne, TN (US) (2011)
Glen Mills, PA (US) (2015 - 2019)
Philadelphia, PA (US) (2009 - 2024)
Plymouth Meeting, PA (US) (2017 - 2024)

Company Filing History:

Incyte Holdings Corporation

patents

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

PI3K Inhibitors

Kinase Inhibitors

TAM Inhibitors

JAK Inhibitors

Aminopyrazine Derivatives

Pyrrolopyrimidine Derivatives

Tertiary Alcohols

Imidazotriazines

Crystalline Forms

Bicyclic Amines

Furo-Pyridine Compounds

Cyclic Hydroxamates

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516065 - Tertiary alcohols as PI3K-γ inhibitors (2026-01-06),

2. 12421197 - Aminopyrazine derivatives as PI3K-γ inhibitors (2025-09-23),

3. 12415809 - Pyrrolotriazine compounds as tam inhibitors (2025-09-16),

4. 12173006 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor (2024-12-24),

5. 12084449 - Imidazotriazines and imidazopyrimidines as kinase inhibitors (2024-09-10),

6. 12030885 - Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors (2024-07-09),

7. 11976073 - Bicyclic amines as CDK2 inhibitors (2024-05-07),

8. 11926630 - Tertiary alcohols as PI3K-γ inhibitors (2024-03-12),

9. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors (2023-10-10),

10. 11261191 - Imidazotriaines and imidazopyrimidines as kinase inhibitors (2022-03-01),

11. 11225486 - Tertiary alcohols as PI3K-γ inhibitors (2022-01-18),

12. 11214573 - Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors (2022-01-04),

13. 11186580 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor (2021-11-30),

14. 11136326 - Pyrrolopyrimidine derivatives as TAM inhibitors (2021-10-05),

15. 11046658 - Aminopyrazine derivatives as PI3K-γ inhibitors (2021-06-29),

Title: The Innovative Journey of David M Burns

Introduction:

David M Burns, a talented inventor hailing from Plymouth Meeting, PA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

David M Burns holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical equipment.

Career Highlights:

With a career spanning over two decades, David M Burns has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only revolutionized industries but has also improved the quality of life for many individuals worldwide.

Collaborations:

Throughout his career, David M Burns has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, David M Burns' passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his position as a respected inventor in the technology sector. His relentless pursuit of excellence continues to inspire the next generation of inventors to think outside the box and create a better future for all.